What is APH's health score?

AMPHENOL CORP /DE/ (APH) has a TradeApes health score of 58 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is APH's estimated fair value?

Based on our 5-year discounted cash flow model, AMPHENOL CORP /DE/'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is APH undervalued or overvalued?

Our model currently rates APH as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

Create an account for unlimited access

AMPHENOL CORP /DE/ (APH)

Technology Overvalued low mixed

$159.06

Updated: 2026-07-12

TradeApes Score

Financial Strength

80 Strong

Operating Trend

60 Healthy

Relative Value

30 Weak

Capital Allocation

55 Mixed

Risk Management

70 Healthy

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

Industry Related Stocks

APPLIED OPTOELECTRONICS, INC. (AAOI) AAON, INC. (AAON) Apple Inc. (AAPL) Antiaging Quantum Living Inc. (AAQL) ABB LTD (ABBNY) ABB LTD (ABLZF)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.